Scarica l'app Stockscreener
40.83
0.12%
0.13
Precedente Chiudi:
$40.96
Aprire:
$40.94
Volume 24 ore:
19,547
Relative Volume:
0.04
Capitalizzazione di mercato:
$1.99B
Reddito:
$447.57M
Utile/perdita netta:
$-38.92M
Rapporto P/E:
-49.19
EPS:
-0.83
Flusso di cassa netto:
$-1.15M
1 W Prestazione:
+2.86%
1M Prestazione:
+25.41%
6M Prestazione:
+101.62%
1 anno Prestazione:
+24.24%
Intervallo 1D:
$40.80
$41.14
Intervallo di 1 settimana:
$38.90
$41.77
Portata 52W:
$18.94
$43.11
Atricure Inc Stock (ATRC) Company Profile
Nome
Atricure Inc
Settore
Industria
Telefono
513-755-4100
Indirizzo
7555 INNOVATION WAY, MASON, OH
Confronta ATRC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
40.84 | 1.99B | 447.57M | -38.92M | -1.15M | -0.83 |
|
ISRG
Intuitive Surgical Inc
|
593.96 | 209.89B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
228.96 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
91.55 | 45.33B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
237.71 | 34.84B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
330.82 | 23.97B | 2.88B | 499.60M | 321.60M | 6.74 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-17 | Ripresa | JP Morgan | Overweight |
| 2024-04-23 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-10-23 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-09-29 | Iniziato | UBS | Buy |
| 2021-08-05 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Reiterato | Needham | Buy |
| 2020-11-06 | Reiterato | Needham | Buy |
| 2020-04-07 | Iniziato | Oppenheimer | Outperform |
| 2020-02-06 | Iniziato | BTIG Research | Buy |
| 2020-01-24 | Reiterato | Needham | Buy |
| 2019-08-13 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | Iniziato | JP Morgan | Overweight |
| 2018-10-04 | Reiterato | Needham | Buy |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-08-02 | Reiterato | Stifel | Buy |
| 2018-06-18 | Reiterato | Needham | Buy |
| 2018-04-27 | Reiterato | Needham | Buy |
| 2018-01-16 | Reiterato | Needham | Buy |
| 2017-11-02 | Reiterato | Needham | Buy |
| 2017-07-28 | Reiterato | Needham | Buy |
| 2017-05-30 | Ripresa | Piper Jaffray | Overweight |
| 2016-06-30 | Ripresa | JMP Securities | Mkt Outperform |
| 2015-10-28 | Reiterato | Needham | Buy |
| 2015-10-06 | Reiterato | Canaccord Genuity | Buy |
| 2015-10-06 | Reiterato | Needham | Buy |
Mostra tutto
Atricure Inc Borsa (ATRC) Ultime notizie
Transcatheter Aortic Valve Replacement Market Future Business - openPR
AtriCure, Inc. (NASDAQ:ATRC) Shares Purchased by Calamos Advisors LLC - MarketBeat
Atrial Fibrillation Systems Market Witness Booming Demand: - openPR
AtriCure (NASDAQ:ATRC) Stock Price Down 4.9%Should You Sell? - MarketBeat
AtriCure, Inc. (NASDAQ:ATRC) Given Consensus Rating of “Buy” by Brokerages - Defense World
AtriCure (NASDAQ:ATRC) Sets New 1-Year HighHere's What Happened - MarketBeat
Why AtriCure, Inc. (ATRC) Is Skyrocketing Now - MSN
AtriCure (NASDAQ:ATRC) Price Target Raised to $51.00 - Defense World
Trading (ATRC) With Integrated Risk Controls - Stock Traders Daily
AtriCure (NASDAQ:ATRC) Hits New 52-Week High Following Analyst Upgrade - MarketBeat
Needham reiterates Buy on AtriCure shares amid impressive growth and solid valuation - MSN
Revenues Tell The Story For AtriCure, Inc. (NASDAQ:ATRC) As Its Stock Soars 29% - Simply Wall St
AtriCure (NASDAQ:ATRC) Price Target Raised to $51.00 at Needham & Company LLC - MarketBeat
AtriCure to Announce Fourth Quarter and Full Year 2024 Financial Results - Business Wire
Deep Dive Into AtriCure Stock: Analyst Perspectives (9 Ratings) - Benzinga
Assenagon Asset Management S.A. Has $4.25 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC) - Defense World
Assenagon Asset Management S.A. Sells 90,029 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Atrial Fibrillation Surgery Market Trends & Insights 2025 -2033 - openPR
AtriCure stock soars to 52-week high, hits $39.08 - MSN
Orthofix Medical (NASDAQ:OFIX) vs. AtriCure (NASDAQ:ATRC) Head-To-Head Contrast - Defense World
AtriCure (NASDAQ:ATRC) Hits New 52-Week HighShould You Buy? - MarketBeat
AtriCure stock soars to 52-week high, hits $39.08 By Investing.com - Investing.com South Africa
AtriCure reports preliminary results for fourth quarter - MSN
AtriCure (ATRC) Stock Surges Over 5% Amid Market Activity - GuruFocus.com
AtriCure, Inc. (NASDAQ:ATRC) Shares Sold by JPMorgan Chase & Co. - MarketBeat
AtriCure projects growth, sets 2025 financial targets By Investing.com - Investing.com Australia
AtriCure projects growth, sets 2025 financial targets - Investing.com
Needham retains AtriCure stock buy rating after revenue beat By Investing.com - Investing.com Australia
AtriCure Q4 revenue prelims beat The Street - Mass Device
Long Term Trading Analysis for (ATRC) - Stock Traders Daily
AtriCure Inc (ATRC) Shares Up 5.13% on Jan 13 - GuruFocus.com
AtriCure (NASDAQ:ATRC) Shares Gap UpShould You Buy? - MarketBeat
AtriCure's (ATRC) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat
Needham retains AtriCure stock buy rating after revenue beat - Investing.com India
AtriCure (NASDAQ:ATRC) Issues FY 2024 Earnings Guidance - MarketBeat
AtriCure Projects Strong Revenue Growth for 2024 - TipRanks
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 2025, and Announces Upcoming Analyst & Investor Day - Business Wire
AtriCure, Inc. (NASDAQ:ATRC) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
AtriCure, Inc. (NASDAQ:ATRC) Given Average Rating of “Buy” by Analysts - Defense World
Atricure Inc Azioni (ATRC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.73%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):